These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


490 related items for PubMed ID: 18446839

  • 1. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
    Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM.
    Head Neck; 2008 Jul; 30(7):946-63. PubMed ID: 18446839
    [Abstract] [Full Text] [Related]

  • 2. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT, Lou WP, Chow C, To KF, Choy KW, Leung AW, Tong CY, Yuen JW, Ko CW, Yip TT, Busson P, Lo KW.
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [Abstract] [Full Text] [Related]

  • 3. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX, Yi H, Qu JQ, He QY, Xiao ZQ.
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [Abstract] [Full Text] [Related]

  • 4. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M, Li X, Shen S, Wang R, Cao L, Tang K, Li G.
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [Abstract] [Full Text] [Related]

  • 5. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
    Lui VW, Yau DM, Cheung CS, Wong SC, Chan AK, Zhou Q, Wong EY, Lau CP, Lam EK, Hui EP, Hong B, Hui CW, Chan AS, Ng PK, Ng YK, Lo KW, Tsang CM, Tsui SK, Tsao SW, Chan AT.
    Oncogene; 2011 Mar 31; 30(13):1518-30. PubMed ID: 21119603
    [Abstract] [Full Text] [Related]

  • 6. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway.
    Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C, Cao L, Tang K, Qian J, Shen SR, Li GY.
    Hum Pathol; 2007 Jan 31; 38(1):120-33. PubMed ID: 16996564
    [Abstract] [Full Text] [Related]

  • 7. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W, Xiao L, Cao C, Hua S, Wu D.
    Oncotarget; 2016 Mar 22; 7(12):15161-72. PubMed ID: 26943030
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ, Zhou R, Zong JF, Lin WS, Tong S, Guo QJ, Lin C, Lin SJ, Chen YX, Chen MR, Chen HL, Ye YB, Pan JJ.
    Cancer Lett; 2019 Apr 10; 447():33-40. PubMed ID: 30684592
    [Abstract] [Full Text] [Related]

  • 9. Translational genomics of nasopharyngeal cancer.
    Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW.
    Semin Cancer Biol; 2020 Apr 10; 61():84-100. PubMed ID: 31521748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
    Chua HH, Yeh TH, Wang YP, Sheen TS, Shew JY, Huang YT, Tsai CH.
    Head Neck; 2008 Dec 10; 30(12):1575-85. PubMed ID: 18798303
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
    Cai L, Ye Y, Jiang Q, Chen Y, Lyu X, Li J, Wang S, Liu T, Cai H, Yao K, Li JL, Li X.
    Nat Commun; 2015 Jul 02; 6():7353. PubMed ID: 26135619
    [Abstract] [Full Text] [Related]

  • 13. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.
    Meng F, Li H, Shi H, Yang Q, Zhang F, Yang Y, Kang L, Zhen T, Dai S, Dong Y, Han A.
    PLoS One; 2013 Jul 02; 8(4):e60821. PubMed ID: 23573286
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
    Liu ZF, Yang J, Wei SP, Luo XG, Jiang QS, Chen T, Gong YQ.
    Kaohsiung J Med Sci; 2020 Nov 02; 36(11):895-903. PubMed ID: 32668092
    [Abstract] [Full Text] [Related]

  • 17. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
    Hsu CL, Lui KW, Chi LM, Kuo YC, Chao YK, Yeh CN, Lee LY, Huang Y, Lin TL, Huang MY, Lai YR, Yeh YM, Fan HC, Lin AC, Lu YJ, Hsieh CH, Chang KP, Tsang NM, Wang HM, Chang AY, Chang YS, Li HP.
    J Exp Clin Cancer Res; 2018 Sep 20; 37(1):233. PubMed ID: 30236142
    [Abstract] [Full Text] [Related]

  • 18. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
    Li W, Ma H, Liu M.
    Mol Biotechnol; 2021 Nov 20; 63(11):1081-1091. PubMed ID: 34236626
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS, Zheng YJ, Wang J, Zhao JY, Yang DK, Liu ZS.
    J Exp Clin Cancer Res; 2019 Feb 21; 38(1):97. PubMed ID: 30791932
    [Abstract] [Full Text] [Related]

  • 20. Current understanding and management of nasopharyngeal carcinoma.
    Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K.
    Auris Nasus Larynx; 2012 Apr 21; 39(2):137-44. PubMed ID: 21592702
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.